Zymeworks INC. 8-K Filing
Ticker: ZYME · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1937653
| Field | Detail |
|---|---|
| Company | Zymeworks INC. (ZYME) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Zymeworks INC. (ticker: ZYME) to the SEC on Dec 30, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.00001 (ich registered Common Stock, par value $0.00001 per share ZYME The Nasdaq Stock Mar).
How long is this filing?
Zymeworks INC.'s 8-K filing is 3 pages with approximately 783 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 783 words · 3 min read · ~3 pages · Grade level 10.4 · Accepted 2025-12-30 17:11:12
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 per share ZYME The Nasdaq Stock Mar
Filing Documents
- d90694d8k.htm (8-K) — 40KB
- 0001193125-25-337268.txt ( ) — 152KB
- zyme-20251230.xsd (EX-101.SCH) — 3KB
- zyme-20251230_lab.xml (EX-101.LAB) — 18KB
- zyme-20251230_pre.xml (EX-101.PRE) — 11KB
- d90694d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZYMEWORKS INC. (Registrant) Date: December 30, 2025 By: /s/ Kenneth Galbraith Name: Title: Kenneth Galbraith Chair of the Board of Directors, President and Chief Executive Officer 3